We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Iron Status Determined in Pregnancy Using the Thomas Plot

By LabMedica International staff writers
Posted on 12 Jan 2016
Print article
The Advia Centaur XP immunoassay system
The Advia Centaur XP immunoassay system (Photo courtesy of Siemens Healthineers - Laboratory Diagnostics)
Iron deficiency anemia (IDA) in pregnancy is common and associated with an increased risk for poor pregnancy outcomes, including intrauterine growth retardation, stillbirth, preterm delivery, low birthweight, and decreased survival of peripartum hemorrhage.

Physiological changes during pregnancy affect routine tests for iron deficiency. The reticulocyte hemoglobin equivalent (RET-He) and serum-soluble transferrin receptor (sTfR) assay are newer diagnostic parameters for the detection of iron deficiency, combined in the Thomas diagnostic plot.

Hematologists at the University of the Free State (Bloemfontein, South Africa) recruited for a study 103 participants, ranging between 18 and 42 years in age (median 24 years), and 50 were primigravidae. The gestation at which they presented for their first antenatal visit varied greatly from five to 36 week and the median gestational age was 18 weeks. Most of the participants (61.1%) were in their second trimester of pregnancy (13- to 28-week gestation) and 32% of participants were human immunodeficiency virus (HIV)-positive.

A full blood count (FBC) with reticulocyte parameters (RET-He) was performed using the Sysmex XE-2100 analyzer (Sysmex Corporation; Kobe, Japan). Serum ferritin was measured on the Advia Centaur XP immunoassay system (Siemens Healthcare Diagnostics Inc.; Tarrytown, NY, USA). The sTfR was determined using the Siemens subsidiary Dade Behring N Latex sTfR kit on a Siemens BN Prospec System nephelometer, and the C-reactive protein (CRP) was measured using the Synchron LX20 instrument and Synchron CRP reagent kit (Beckman Coulter; Fullerton, CA, USA).

The scientists found that according to the Thomas plot, 72.8% of the participants had normal iron stores and erythropoiesis. Iron-deficient erythropoiesis was detected in 12.6%. A third of participants were anemic. Serum ferritin showed excellent sensitivity but poor specificity for detecting depleted iron stores. Participants in their first trimester of pregnancy were less likely to have iron-deficient erythropoiesis and functional iron deficiency than participants in the third trimester. HIV status had no influence on the iron status of the participants.

The authors concluded that their findings reiterate that causes other than iron deficiency should be considered in anemic individuals. When compared with the Thomas plot, a low serum ferritin is a sensitive but nonspecific indicator of iron deficiency. The Thomas plot may provide useful information to identify pregnant individuals in whom hematological parameters indicate limited iron availability for erythropoiesis. The study was first published online on November 14, 2015, in the International Journal of Laboratory Hematology.

Related Links:

University of the Free State 
Sysmex Corporation 
Siemens Healthcare Diagnostics Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.